黃酮類化合物市場－全球產業規模、佔有率、趨勢、機會及預測（按類型、應用、形態、地區和競爭格局分類，2021-2031年）

全球類黃酮市場預計將從 2025 年的 16.2 億美元成長到 2031 年的 22.9 億美元，複合年成長率為 5.94%。

黃酮類化合物是一類用途廣泛的多酚類次級代謝物，廣泛存在於植物中，它們不僅是重要的色素，還具有優異的抗氧化功效。推動該市場成長的主要因素是文明病慢性疾病發病率的上升以及消費者對天然預防保健方式的明顯偏好。此外，黃酮類化合物在醫藥和食品行業中作為天然色素和功能性成分的日益廣泛應用，也為這一積極的市場趨勢提供了有力支撐。

然而，該行業在健康聲明的複雜法規結構和植物萃取物的標準化方面面臨著許多挑戰。各地不同的品管通訊協定和嚴格的核准程序可能會阻礙這些產品的順利商業分銷。儘管監管複雜，市場需求依然強勁。根據美國植物委員會 (ABC) 2024 年的報告，美國草藥膳食補充劑的零售額達到了創紀錄的 132.3 億美元。這項數據凸顯了天然化合物巨大的商業性潛力，並顯示儘管面臨監管挑戰，消費者對天然化合物的興趣仍持續高漲。

市場促進因素

消費者對機能性食品和強化飲料的需求不斷成長，這主要得益於人們對健康營養的日益重視。這一趨勢促使製造商改進產品配方，添加植物性生物活性化合物，以提供抗氧化功效，同時保持潔淨標示的完整性。植物性食品協會於2024年4月發布的《2023年市場報告》重點闡述了這種向天然成分轉變的經濟影響。報告顯示，美國植物性食品的零售額達81億美元。這一可觀的數字表明，消費者群體願意為天然產品買單，這直接惠及了為這些強化產品提供所需植物營養素的類黃酮供應鏈。

慢性病發病率的上升趨勢推動了膳食補充劑的普及，同時也確立了類黃酮作為預防保健方法中重要成分的地位。隨著文明病發病率的增加，旨在減少發炎和氧化壓力的富含多酚的補充劑的消費量也相應增加。為了凸顯這項健康緊迫性，美國癌症協會於2024年1月發布的《2024年癌症事實與數據》報告估計，美國新增癌症病例將達到2,001,140例，強調了治療和預防措施的重要性。這項負擔正在推動市場成長，負責任營養委員會（CRN）在2024年10月進行的一項調查發現，75%的美國成年人表示使用膳食補充劑，這表明這些成分擁有巨大的市場潛力。

市場挑戰

全球類黃酮市場的擴張受到許多因素的顯著限制，包括複雜的健康聲明法規環境以及萃取物缺乏標準化。由於類黃酮植物來源，因此在不同批次的產品中保持化學成分和活性成分含量的一致性面臨著巨大的科學挑戰。這種差異性使得監管核准更加複雜，主要市場的監管機構要求提供嚴謹的證據來支持其功能性聲明。缺乏標準化的臨床級數據往往限制了製造商做出具體療效聲明的能力，從而限制了他們產品差異化以及向潛在客戶傳達產品價值的能力。

對可靠、檢驗的健康聲明的限制造成了行業能力與消費者接受度之間的差距。當企業因法律原因無法詳細說明富含類黃酮產品的特定預防功效時，潛在買家不太可能意識到自身的需求。這種猶豫不決反映在近期消費者數據中：2024 年責任營養委員會 (CRN) 的一項調查發現，41% 的膳食補充劑非使用者表示「不覺得有必要」​​是他們不服用膳食補充劑的主要原因。這項發現凸顯了監管對健康訊息的限制如何將很大一部分人群拒之門外，從而阻礙了此類產品更廣泛的商業性應用。

市場趨勢

一個顯著的行業趨勢是將類黃酮融入抗衰老和光防護膚產品中，利用其中和自由基和減少紫外線引起的皮膚損傷的能力。化妝品研發人員正擴大將白藜蘆醇、兒茶素和槲皮素等化合物添加到高級精華液中，以滿足消費者對臨床級植物來源美容解決方案的需求。這種對局部外用藥妝品的探索，建立了一個有別於傳統口服補充劑的高價值品類，並推動了對能夠穿透皮膚屏障的高純度萃取物的需求。該領域的經濟實力顯而易見。根據歐萊雅集團於2024年2月發布的2023年度報告，該公司皮膚科美容部門的同店銷售額成長了28.4%，超過了整體美容市場的成長速度。這項結果證實了消費者對富含活性成分的健康護膚品的強勁需求。

同時，隨著食品飲料生產商積極減少人工添加劑的使用，原料供應鏈也正在經歷一場變革，合成色素也逐漸被花青素取代。花青素是一種類黃酮，能夠產生紅色、紫色和藍色的植物色素，其應用日益廣泛，不僅因為其抗氧化特性，更因為其作為一種穩定、天然的合成色素替代品，尤其可以替代紅色40號等合成染料。這種轉變體現了「潔淨標示」的趨勢，迫使供應商提高從接骨木莓和黑胡蘿蔔等原料中的提取能力，以滿足工業規模的需求。 GNT集團於2024年4月發布的《2023年永續發展報告》揭示了這項變化的規模。報告顯示，自2020年以來，該公司植物來源色素EXBERRY全球銷售量的成長超過50%，顯示該產業正持續向類黃酮色素轉型。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球類黃酮市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依類型（花青素、黃酮、異黃酮、黃烷-3-醇、黃酮醇、花黃素、其他）
  • 依應用領域（機能飲料、機能性食品、營養補充品等）
  • 依型態（粉末與液體）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

6. 北美類黃酮市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

7. 歐洲類黃酮市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

8. 亞太地區類黃酮市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

9. 中東和非洲類黃酮市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章 南美洲類黃酮市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章 全球類黃酮市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Cayman Chemical Company
• Quercegen Pharmaceutical
• Foodchem International Corporation
• INDOFINE Chemical Company, Inc.
• Toroma Organics Ltd
• Pharmachem Laboratories Inc.
• Organic Herb Inc.
• Phytocompounds
• Indena SpA
• Merck KGaA

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Flavonoid Market is projected to expand from USD 1.62 billion in 2025 to USD 2.29 billion by 2031, registering a compound annual growth rate of 5.94%. Flavonoids, a versatile group of polyphenolic secondary metabolites found abundantly in plants, function as vital pigments and offer substantial antioxidant benefits. The market is primarily propelled by the rising incidence of chronic lifestyle-related disorders and a decisive consumer shift toward natural preventive healthcare options. Additionally, the growing utilization of these substances as natural coloring agents and functional components within the pharmaceutical and food industries actively sustains this positive market trajectory.

However, the industry faces substantial obstacles regarding the intricate regulatory framework for health claims and the standardization of botanical extracts. Varying quality control protocols and rigorous approval procedures across different territories can hinder the smooth commercial distribution of these goods. Despite these regulatory complexities, market demand remains resilient; the American Botanical Council reported in 2024 that retail sales of herbal dietary supplements in the United States hit a historic high of 13.23 billion dollars. This statistic highlights the robust commercial potential for natural compounds, indicating that consumer interest persists even amidst regulatory challenges.

Market Driver

The escalating consumer demand for functional foods and fortified beverages serves as a major market accelerator, as individuals increasingly prioritize nutrition for health enhancement. This movement compels manufacturers to modify product formulations by including bioactive plant compounds that provide antioxidant advantages while maintaining clean-label integrity. The economic significance of this transition toward natural ingredients is highlighted by the Plant Based Foods Association's April 2024 "2023 State of the Marketplace" report, which noted that U.S. retail sales of plant-based foods totaled 8.1 billion dollars. This substantial figure indicates a consumer demographic ready to spend on natural formulations, thereby directly benefiting the flavonoid supply chain that furnishes the necessary phytonutrients for these enhanced products.

The rising prevalence of chronic illnesses is concurrently boosting the adoption of nutraceuticals, establishing flavonoids as essential components in preventive healthcare approaches. As the frequency of lifestyle-associated conditions grows, there is a corresponding rise in the intake of polyphenol-dense supplements designed to reduce inflammation and oxidative stress. Highlighting this health urgency, the American Cancer Society's "Cancer Facts & Figures 2024," released in January 2024, estimated 2,001,140 new cancer cases in the United States, emphasizing the critical need for therapeutic and preventative measures. This burden supports market growth, a fact reinforced by the Council for Responsible Nutrition's October 2024 survey, where 75% of U.S. adults reported using dietary supplements, illustrating the vast potential market for these ingredients.

Market Challenge

The expansion of the Global Flavonoid Market is significantly hindered by a complicated regulatory environment regarding health claims and a lack of extract standardization. Since flavonoids originate from a wide variety of botanical sources, maintaining consistent chemical profiles and potency levels across different production batches presents a considerable scientific challenge. This variability complicates regulatory approvals, as authorities in key markets demand rigorous proof to substantiate functional ingredient claims. In the absence of standardized, clinical-grade data, manufacturers are often barred from asserting specific therapeutic benefits, which restricts their capacity to distinguish their offerings and convey their value to potential customers.

This restriction on making robust, verified health claims fosters a gap between industry capabilities and consumer uptake. When companies are legally prevented from detailing the specific preventative advantages of flavonoid-rich products, prospective buyers often fail to see the necessity of the purchase. This hesitation is reflected in recent consumer data; according to the Council for Responsible Nutrition in 2024, 41 percent of non-users identified a lack of perceived need as their main reason for shunning dietary supplements. This finding underscores how regulatory constraints on health messaging contribute to keeping a large segment of the population out of the market, effectively impeding wider commercial adoption.

Market Trends

A prominent trend shaping the industry is the incorporation of flavonoids into anti-aging and photoprotective skincare products, leveraging their ability to neutralize free radicals and reduce UV-related skin damage. Cosmetic developers are increasingly blending compounds like resveratrol, catechins, and quercetin into advanced serums to meet consumer desires for clinical-grade, plant-based beauty solutions. This move into topical cosmeceuticals establishes a high-value sector separate from conventional oral supplements, fueling the need for high-purity extracts that can penetrate the skin barrier. The economic strength of this focus is evident; L'Oreal Group's "Annual Report 2023," published in February 2024, revealed that their Dermatological Beauty Division saw like-for-like sales grow by 28.4 percent, surpassing the general beauty market and validating the strong consumer demand for active, health-oriented skincare ingredients.

Concurrently, the substitution of synthetic colorants with anthocyanins is transforming the ingredient supply chain as food and beverage producers aggressively remove artificial additives. Anthocyanins, a flavonoid subclass that gives plants their red, purple, and blue colors, are being adopted not only for their antioxidant properties but primarily as stable, natural replacements for synthetic dyes such as Red 40. This transition operationalizes the clean label trend, compelling suppliers to increase extraction capacities from sources like elderberries and black carrots to satisfy industrial volume demands. The magnitude of this shift is highlighted by GNT Group's April 2024 "Sustainability Report 2023," which noted that global sales of their plant-based EXBERRY colors have risen by over 50 percent since 2020, signaling a lasting shift toward flavonoid-based pigmentation in the industry.

Key Market Players

• Cayman Chemical Company
• Quercegen Pharmaceutical
• Foodchem International Corporation
• INDOFINE Chemical Company, Inc.
• Toroma Organics Ltd
• Pharmachem Laboratories Inc.
• Organic Herb Inc.
• Phytocompounds
• Indena S.p.A
• Merck KGaA

Report Scope

In this report, the Global Flavonoid Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Flavonoid Market, By Type

• Anthocyanin
• Flavones
• Isoflavones
• Flavan-3-ols
• Flavonol
• Anthoxanthin
• Others

Flavonoid Market, By Application

• Functional Beverages
• Functional Food
• Dietary Supplements
• Others

Flavonoid Market, By Form

• Powder Vs Liquid

Flavonoid Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Flavonoid Market.

Available Customizations:

Global Flavonoid Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Flavonoid Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Anthocyanin, Flavones, Isoflavones, Flavan-3-ols, Flavonol, Anthoxanthin, Others)
  • 5.2.2. By Application (Functional Beverages, Functional Food, Dietary Supplements, Others)
  • 5.2.3. By Form (Powder Vs Liquid)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Flavonoid Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By Form
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Flavonoid Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By Form
  • 6.3.2. Canada Flavonoid Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By Form
  • 6.3.3. Mexico Flavonoid Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By Form

7. Europe Flavonoid Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By Form
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Flavonoid Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By Form
  • 7.3.2. France Flavonoid Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By Form
  • 7.3.3. United Kingdom Flavonoid Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By Form
  • 7.3.4. Italy Flavonoid Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By Form
  • 7.3.5. Spain Flavonoid Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By Form

8. Asia Pacific Flavonoid Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By Form
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Flavonoid Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By Form
  • 8.3.2. India Flavonoid Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By Form
  • 8.3.3. Japan Flavonoid Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By Form
  • 8.3.4. South Korea Flavonoid Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By Form
  • 8.3.5. Australia Flavonoid Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By Form

9. Middle East & Africa Flavonoid Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By Form
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Flavonoid Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By Form
  • 9.3.2. UAE Flavonoid Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By Form
  • 9.3.3. South Africa Flavonoid Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By Form

10. South America Flavonoid Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By Form
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Flavonoid Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By Form
  • 10.3.2. Colombia Flavonoid Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By Form
  • 10.3.3. Argentina Flavonoid Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By Form

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Flavonoid Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Cayman Chemical Company
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Quercegen Pharmaceutical
• 15.3. Foodchem International Corporation
• 15.4. INDOFINE Chemical Company, Inc.
• 15.5. Toroma Organics Ltd
• 15.6. Pharmachem Laboratories Inc.
• 15.7. Organic Herb Inc.
• 15.8. Phytocompounds
• 15.9. Indena S.p.A
• 15.10. Merck KGaA

16. Strategic Recommendations

17. About Us & Disclaimer